Cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular comorbidities.

White, William B

Cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular comorbidities. [electronic resource] - American heart journal Jul 2012 - 14-20 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1097-6744

10.1016/j.ahj.2012.04.011 doi


Allopurinol--adverse effects
Cardiovascular Diseases--complications
Double-Blind Method
Febuxostat
Gout--complications
Gout Suppressants--adverse effects
Humans
Prospective Studies
Thiazoles--adverse effects